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Abstract
Practice Problem: Substance abuse disorder (SUD) has become an increasingly
prevalent community health problem worldwide, affecting individuals in all geographical regions
regardless of age, race, sex, and socioeconomic status, despite decades of efforts to find a
solution (Bowen et al., 2014). A lack of treatment engagement and substance‐misuse crisis calls
attention to the effectiveness of relapse‐sensitive care and treatments.
PICOT: The question addressed in this evidence-based project was “ In adults over 18
years of age with substance use disorder (P), how does the effect of mindfulness-based treatment
(I), compared with no mindfulness-based treatment (C), reduce the risk of relapse (O), in 3
months (T)?”
Evidence: Evidence exists to support that Mindfulness-based intervention (MBI)
significantly reduced the incidence of relapse in adult patients with a history of SUD by
decreasing symptoms related to substance abuse craving or use.
Intervention: Mindfulness-based practice consisting of meditation and mindful breathing
exercises, motivational interviewing and relapse prevention cognitive therapy was implemented
to reduce incidence of relapse in adults with a history of SUD.
Outcome: Findings revealed a less than 15% reduction in incidence after three months
of MBI implementation.
Conclusion: The results indicate that the reduction in the risk of relapse in adult patients
with a history of SUD post implementation was not significantly significant. The reduction also
indicated a clinically significant improvement in relapse outcomes two months after
implementing MBI.
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Mindfulness-based Intervention and Relapse Rates
in Adults with a History of Substance Use Disorder
Substance abuse disorder (SUD) is a disease that spares no population and is
characterized as a primary, chronic, and relapsing disease (American Society of Addiction
Medicine [ASAM], 2016). As a country, we have a serious substance misuse problem with the
use of alcohol, illegal drugs, and/or prescribed medications in ways that produce harms to
ourselves and those around us (McLellan, 2017). SUD is a significant problem that can
reasonably be considered a lifestyle problem, but there are effective prevention policies and
practices that could significantly reduce the harms, risk of relapse and costs of these problems
(McLellan, 2017). The purpose of this DNP project was to evaluate the effect of mindfulnessbased interventions in reducing relapse rates in adults with a history of substance abuse disorder
who are patients at a substance abuse treatment facility in Woodlawn, Maryland.
Substance use includes alcohol, tobacco, cannabis, stimulants, and opioids. With
substance abuse disorder, relapse and noncompliance are challenges for both the healthcare
provider and the patient. Therefore, prevention and management of substance use disorder is
considered one of the top priorities and has become a major public health problem for healthcare
systems. Effective treatment involves improved access to care, tailoring a program to the
patients’ needs, and assessing and modifying treatment modalities based on patient assessment
(National Institute of Drug Abuse [NIDA],2016). Relapse is highly prevalent following
substance abuse treatment, supporting the need for improved aftercare interventions (Bowen et
al., 2014). Relapse is defined conceptually as either a transition to regression or a progression in
the process of recovery, prompted by a return to the previous behavior of substance use, despite
the intention to stay abstinent (Moon and Lee, 2020).
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Relapse prevention therapy as a specific intervention is one of several evidence-based
practices for substance use disorders. Non-pharmacological treatments such as “counseling”,
“self-help”, and “behavioral therapies” have been proven as effective therapies that can reduce
the risk of relapsing (Tran et al.,2019).
Significance of the Practice Problem
Substance use disorder (SUD) has become an increasingly prevalent community health
problem worldwide, affecting individuals in all geographical regions regardless of age, race, sex,
and socioeconomic status, despite decades of efforts to find a solution (Bowen et al., 2014).
SUDs include substance dependence or abuse that can ultimately cause health problems,
disability, and the failure to meet responsibilities at work, school, or home. In addition,
intoxication, misuse, and overdose can be life-threatening and result in medical emergencies.
Opioids are the main driver of drug overdose deaths, which frequently occur during the relapse
phase because of the decreased level of tolerance after a period of abstinence. Substance use is
often initiated in adolescence, but it is during adulthood that prevalence rates for SUDs peak
(Schulte and Hser, 2014).
According to the 2018 National Survey on Drug Use and Mental Health, approximately
20.3 million people ages 12 or older suffer from a SUD (Korecki et al., 2020). Approximately 23
million Americans suffer from SUDs with only an estimated 10% receiving any treatment
(Pating et al., 2012). And 40% to 60% will relapse within one year (Bowen et al., 2014). In the
U.S., there were 67,367 drug overdose deaths reported in 2018, 4.1% fewer deaths than in 2017
(NIDA, 2020). In Maryland, nearly 90% of drug overdose deaths involved opioids in 2018; a
total of 2,087 deaths (NIDA, 2020). A lack of treatment engagement and substance‐misuse crisis
calls attention to the effectiveness of relapse‐sensitive care and treatments.
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In 2017, the Governor of Maryland recognized this public health challenge and declared a
State of Emergency in response to the substance abuse crisis ravaging communities in Maryland.
The Governor developed efforts to combat Maryland’s opioid epidemic through a $10 million
grant to combat the drug epidemic across the state. The money was dedicated to prevention,
education, enforcement, public safety, and treatment and recovery.
Substance use disorder is a significant public health problem associated with considerable
social and economic costs in the United States and throughout the world (Korecki et al., 2020).
Substance abuse results in mortality, decreased quality of life, and heavy costs to society, both
monetary and in terms of lost human potential. Recent reports estimated that annual costs in the
United States are approximately USD $193 billion for illicit drug use, USD $223 billion for
excessive alcohol use, and USD $193 billion for tobacco use (Schulte and Hser, 2014). The
estimated cost associated with substance use in the U.S. as measured by crime, lost work
productivity, and health care is nearly $740 billion annually (Korecki et al., 2020).
SUDs can result in general health deterioration and specific, ongoing conditions (Schulte
and Hser, 2014). SUDs have been linked to increased risk for cardiovascular problems and heart
disease. Substance use also increases risk for infectious disease. SUD can also have a wide
range of short and long term, direct and indirect effects (NIDA, 2016). Short term effects include
changes in appetite, labile changes in blood pressure and heart rate, overdose or even death.
Long term effects can include heart or lung disease, cancer, mental illness, Hepatitis and
HIV/AIDS. Not to mention, long term drug use can also lead to addiction. The indirect effects of
SUD include not just the person using drugs but also those around them.
There is a recognized psychological and social need of patients with substance use
disorders that presents as a challenge for healthcare providers, requiring a multidisciplinary

MINDFULNESS AND RELAPSE PREVENTION

6

approach that includes medications, psychosocial treatment, and education to assist the patient
with disease management.
PICOT Question
The question addressed in this evidence-based project is: In adults over 18 years of age
with substance use disorder (P), how does the effect of mindfulness-based treatment (I),
compared with no mindfulness-based treatment (C), reduce the risk of relapse (O), in 3 months
(T)?
The population is adults over the age of 18 years old with a history of substance use
disorder. The intervention is mindfulness-based treatment which includes modifying attitudes
and behaviors related to drug abuse and increasing life skills to handle stressful circumstances
and environmental cues that may trigger intense craving for drugs and prompt another cycle of
compulsive abuse (NIDA, 2020). MBI incorporates mindfulness practice such as meditation and
mindful breathing exercises, motivational interviewing and relapse prevention cognitive therapy
that is administered by a trained healthcare professional (Bowen et al., 2014). Mindfulness
training includes “maintaining a moment-by-moment awareness of one’s thoughts, feelings,
bodily sensations, and surrounding environment” (Li et al., 2017). Out of the 11 studies
reviewed, all 11 supported the use of MBI and its efficacy as measured by lowering the risk of
relapse. The comparative intervention is no mindfulness-based treatment. The intended
outcome was reduction in the risk of relapse by more than 15% from the baseline of 40% risk of
relapse, with the implementation of MBI after 3 months. Relapse means to fall or slide back into
a previous state. Relapse was measured as a change in the addictive behavior and recurrence of
symptoms related to substance abuse craving or use after MBI. Lastly, the timeframe was within
3 months.
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Evidence-Based Practice Framework & Change Theory
The John's Hopkins evidence-based practice framework guides the development and
implementation of the project by establishing the goal of the model to ensure that all relevant and
practical research findings and best practices are appropriately incorporated into patient care
(Dang and Dearholt, 2017). This model seeks to identify interventions supported by empirical
research to support implementation strategies which, includes the process of transferring
treatment into a clinical setting. 11 articles reviewed provided support that MBI is effective in
reducing the rate of relapse when used in patients with SUD.
Change Theory
The Transtheoretical Model (TTM) is a framework for understanding positive healthbehavior changes (Prochaska et al., 1992). The TTM’s process of predicting a person’s success
or failure in achieving a proposed behavioral change is relevant to the change project. TTM
emphasize the difference between motivation for change and motivation for treatment. There are
five leading measures associated with TTM: Precontemplation, contemplation, preparation,
action, and maintenance.
In the precontemplation stage, individuals are not considering change and are not
interested in getting help for the behavior. Precontemplators are often characterized as resistant
or unmotivated and tend to avoid information, discussion, or thought with regard to the targeted
health behavior (Prochaska et al., 1992). They typically don’t see the behavior as being a
problem. They are not interested in being advised to quit their addiction. The behavior is
usually leading to a negative outcome from their addiction or substance abuse that leads them to
the contemplation stage.
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In the contemplation stage, individuals are thinking about changing or quitting the
addictive behavior usually within the next 6 months. They are more aware of the benefits of
changing, but remain keenly aware of the costs (Prochaska, Redding, & Evers, 1997). They may
be opened to learning about different strategies for controlling or quitting the addictive behavior,
without committing or promising to make a change. Individuals may remain at this stage for
months to years before either returning to the precontemplation stage or progressing to the next
stage, the preparation stage.
In the preparation stage, individuals have moved forward to planning and preparing for
carrying out changes they learned about in the contemplation stage. During this stage, an
individual may plan the kind of change that may need to be made, for example, an inpatient or
outpatient treatment program and ceasing the drug abuse behavior.
The action stage is the focus for many people attempting to overcome substance abuse.
This is the stage where change of behavior starts happening. This includes physically enrolling
in treatment where support is provided to help control the addiction or behavior. The action
stage doesn’t necessarily happen all at once and can occur in small, gradual steps.
Lastly, the maintenance stage of TTM focuses on the continuation of any progress made
in the action stage, including maintaining abstinence from alcohol or drugs. The goal was to
prevent relapse and consolidate gains secured during the action phase. This is seen as the most
challenging stage especially after a period of time has lapsed from when the initial goal was met,
and now individuals are more complacent and start to think that a small or minor lapse will make
no significant difference.
After the change has been implemented, it must be a part of the organization’s culture for
it to be successful and sustained. The protocols developed with MBI becomes the standard

MINDFULNESS AND RELAPSE PREVENTION

9

clinical practice for this project. This includes the process of using The Transtheoretical Model
in the implementation of a behavior modification treatment plan, adopting a collaborative
approach between providers and staff of the project site to develop a structural change that will
fit into the workflow to ensure support and sustainability of the project. The intended outcome
was for participants to possess an awareness of triggers and habitual responses and then make a
mindful choice that decreases the likelihood of relapse, while also increasing self-efficacy so
they are less likely to consume the previously desired substance. This is where the change is
now their new habit and standard.
Evidence Search Strategy
Several databases were used to locate current literature on substance use disorder and
relapse prevention and to support the use of behavioral modification. In searching databases
located in the library at University of Saint Augustine, an extensive search was performed
utilizing CINAHL, PubMed and Google Scholar. The combined search used keywords such as
“substance abuse”, “relapse”, “mindfulness-based treatment”, and “substance use disorder”. The
initial search criteria returned 786 articles related to the topics. Articles included were current
articles, published from 2012- 2020, and were related to the PICOT question. Additional filters
used include adults, articles written in English and USA as the geographic area. Exclusion
criteria included peer-reviewed journals published before 2012. Studies were then selected that
addressed the role of behavioral management in recovery and prevention of relapse and
duplicated articles were removed. After screening the titles and abstracts that did not relate to
the PICOT question, 26 articles were excluded. A total of 11 articles were included.
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Evidence Search Results
An extensive search was done using three databases: CINAHL, PubMed, and Google
Scholar researching evidenced based articles between 2012-2020. Each search generated
research articles with the following relevant results; CINAHL 49 articles, PubMed 136 articles,
and Google Scholar 93 articles. A literature review was completed to determine the quality of
each article. Citations were screened for duplication, and there were 73 non duplicated articles
related to substance use disorder and relapse prevention to support the use of behavioral
modification. After the inclusion and exclusion criteria were considered, 52 articles were
excluded. After screening the titles and abstracts that did not relate to the PICOT question, 21
articles were retrieved. A PRISMA model search strategy is provided in Appendix A.
Literature grading was completed to determine the Evidence Level and Quality Guide of
each body of work. Based on the level of evidence outlined by Johns Hopkins Evidence Based
Practice Model (Dang and Dearholt, 2017), eight quantitative studies provided Level I evidence
with a quality rating of high or good quality. Randomized controlled trials (RCT) were included
in Level I evidence. The remaining three articles were Evidence Level II and III and included
Quasi-experimental studies and with high to good quality grades. Among all of the articles, each
mentioned using Mindfulness-Based Relapse Prevention as a therapeutic approach for reducing
relapse in individuals with a history of substance use or misuse. In addition, 7 studies
specifically targeted the outcome of reducing relapse rates and increasing the rate of abstinence.
Themes from the Literature
The synthesis of the literature offers evidence and support to address the components of
the PICOT question. Following an in-depth evaluation of the literature utilizing evidence tables
provided in Appendix B, the results consisted of 11 quality studies and are as follows: Eight
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randomized control trials and three systematic reviews. The specific themes identified include
efficacy of Mindless Based Interventions and relapse prevention.
Treatment Setting
Treatment setting was considered because the treatment environment and accessibility of
support plays a major factor in SUD treatment and relapse prevention (Bautista et al., 2019). Out
of 11 studies, 10 were conducted in a SUD specialty care setting and utilized MBI (Bowen et al.,
2010; Bowen et al., 2014b; Chisea and Serretti, 2014; Witkiewitz et al., 2013b; Korecki et al.,
2013; Roos et al., 2017; Davis et al., 2018; Witkiewitz and Bowen, 2010; Li et al., 2017; Bautista
et al., 2019). These studies included an inpatient or outpatient treatment facility. One study
focused more on a home practice approach to maintain more therapeutic benefits, as this
approach was associated with significantly lower alcohol and other drug use and cravings (Grow
et al., 2015). All RCTs included MBI in a group setting with the exception of the study by
Grow et al., 2015.
Participants
No study had only females or only males. Roos et al., 2017; Bowen et al., 2014a;
Witkiewitz and Bowen, 2010, included participants 18 years and older with an average age of 40
and had a history of various substance abuse of alcohol, drugs, and opiates. Out of 11 studies, no
study restricted participants by race or primary substance abuse. All studies except one
(Witkiewitz et al., 2013), excluded participants with a history of mental health disorders.
Effects of MBI on substance abuse
A critical appraisal of current evidence is crucial in determining the effects of MBI on
substance abuse and how it’s been increasingly developed and evaluated for the treatment of
SUD (Korecki et al., 2013). All 11 studies found that mindfulness-based treatment was
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associated with reducing the level of craving for substance use, increasing abstinence rates, and
supporting the efficacy of SUD treatment (Bowen et al., 2010; Bowen et al., 2014b; Chisea and
Serretti, 2014; Witkiewitz et al., 2013b; Korecki et al., 2013; Roos et al., 2017; Davis et al.,
2018; Grant et al., 2017; Witkiewitz and Bowen, 2010; Li et al., 2017; Bautista et al., 2019).
Bowen et al., (2014) adds that mindfulness-based treatment teaches patients how to remain in
contact with and relate differently to challenging affective or physical states, using alternatives to
avoidant-based coping, recognizing maladaptive behaviors, and increasing contact with natural
contingencies. Furthermore, mindfulness promotes awareness and helps individuals gain
awareness of how substance cues trigger the experience of craving. The total length of MBI
ranged from 2 to 8-hour intervention sessions over 8 weeks (Bowen et al., 2010; Bowen et al.,
2014b; Witkiewitz et al., 2013b).
The use of MBI to decrease relapse prevention
Mindfulness based treatment is a promising intervention for substance misuse and relapse
prevention (Li et al., 2017). Mindfulness-based relapse prevention is a behavioral treatment for
SUD that shows promise in enhancing the long-term outcomes among individuals recovering
from SUDs (Bowen et al., 2011). Mindfulness treatment is more effective in reducing the
number of days of substance use, craving, and substance related problems, increasing the number
of days of abstinence (Bowen et al., 2010; Li et al., 2017). The benefit of relapse prevention
according to the reviewed studies include helping individuals identify situations that may trigger
relapse and being able to utilize cognitive and behavioral skills to cope with substance abuse
(Grant et al., 2017). Four studies explored the problem of preventing relapse and included data
that supports the benefit of MBI for relapse prevention (Bowen et al.,2010; Bowen et al., 2014b;
Li et al., 2017; Dingle and Bowen, 2012). This data included whether MBI is effective and safe

MINDFULNESS AND RELAPSE PREVENTION

13

in reducing relapse, frequency, and quantity of substance use, craving symptoms as well as
improving functional status, recovery outcomes, and health related quality of life (Bowen et
al.,2010; Bowen et al., 2014b; Li et al., 2017; Dingle and Bowen, 2012). While 7 out of the 11
studies found significant effects to reduce cravings as well as increased mindfulness (Witkiewitz
and Bowen, 2010; Witkiewitz et al., 2012; Davis et al., 2018; Chisea and Serretti, 2014; Korecki
et al., 2013; Grow et al., 2015). This includes raising awareness of automatic processes
associated with craving, substance seeking, and urges (Li et al., 2017).
Practice Recommendations
Based on the synthesis of the literature, a generalized consensus was established that
Mindfulness-Based Interventions is an appropriate behavioral modification strategy for
addressing behavioral health issues like SUD. The most common type of MBI for SUD is
Mindfulness based relapse prevention, which posits that it is a “novel mindfulness-based
aftercare approach, which integrates core aspects of relapse prevention with practices adapted
from and [mindfulness based cognitive therapy]”, (Bowen et al., 2014b). Mindfulness-based
relapse prevention is an optimal intervention and treatment for preventing relapse among
individuals with substance use symptoms. Thus, the efficacy for mindfulness-based
interventions is strong. Specifically, MBRP was developed to target negative thought processes
such as rumination and craving which both play significant roles in substance use relapse
(Witkiewitz et al., 2013). MBRP adds an element of traditional cognitive behavioral exercises
that aid in identifying high risk situations while creating alternative responses and coping
strategies to respond to those triggers (Witkiewitz and Bowen, 2010).
The components of MBRP includes 2-hour sessions for 8 weeks that focuses on
practicing mindful awareness and integrating mindfulness practice into daily life. Midway
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through the program, sessions focused on acceptance of present experience, and application of
mindfulness practices to relapse prevention. Concluding with sessions that addressed self-care,
support networks, and lifestyle balance (Bowen et al., 2010). Key implementation strategies
included increasing staff awareness of mindfulness-based relapse prevention, along with weekly
monitoring, auditing, and providing constructive feedback to the staff.
Setting, Stakeholders, and Systems Change
A drug rehabilitation facility in Woodlawn, Maryland served as the setting for the
project. The substance abuse rehabilitation facility provides a 24 hour therapeutically planned
living and rehabilitative intervention environment for the treatment of individuals with disorders
in the abuse of drugs, alcohol, and other substances such as cannabis, stimulants, and opioids.
Due to COVID 19 restrictions, the program was limited to 12 persons which consisted of adult
male and female clients over the age of 18, with a history of substance use, and who successfully
completed aftercare within the last 6 months.
Organizational need for the project stemmed from the recommendation of the Medical
Director. The increasing incidence and prevalence of substance use disorders and returning to
substance use (i.e., relapse) following treatment is common. Therefore, underscoring the need
for effective treatments that will help individuals maintain long-term reductions in substance use
(Korecki et al., 2020). Despite best efforts, relapse and noncompliance with treatment are issues
that challenge healthcare professionals. Due to high relapse rates, substance use disorder (SUD)
has become known as a chronic relapsing disorder (Tkacz et al., 2012). In addition, SUD has a
negative impact on the individual, family unit, and the community.
Stakeholders for this evidence-based change project included the Medical Director,
healthcare providers and mental health therapist, the participant, and family members.
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Sustainability plans included taking a multidisciplinary team approach with continuous
monitoring for long term recovery support. This included a structured recovery support system
of professionals, family, and friends. Continuous monitoring included regular updates to the key
stakeholders of the project’s progress, ongoing organizational and leadership support, auditing
and providing constructive feedback.
An organizational strength, weakness, opportunities, and threats (SWOT) analysis was
conducted to assess the organization. Strengths identified included relapse rate data that supports
the need for the project, multidisciplinary team with open to feedback from stakeholders, and
highly experienced clinical team. Weaknesses included public awareness of the services and
lack of participation among participants. Some opportunities are the rehabilitation facility’s
interest in providing support to participants at risk for relapse and the potential of networking
with community stakeholders. Threats included time constraints for this project coupled with the
occurring pandemic and failure to document correctly or lack of motivation to complete the
questionnaire. The SWOT analysis is provided in Appendix C.
The vision of the project was to empower adults with a history of substance use disorder
by supporting them in identifying situations that trigger relapse. This vision supports the vision
of the rehabilitation facility, “to address the needs of the person served by providing assistance
with issues caused by substance use disorders.” The projects mission was to lower the risk of
relapse in substance use in the adult population. The level of system change that the project
created was micro-level because it is a contained system that includes intra and interpersonal
relationships. This micro system comprises of the health professionals who work directly with
patients and their families to obtain the desired outcome.
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Implementation Plan with Timeline and Budget
TTM framework was appropriate for my project. TTM guides the implementation of
MBI in participants 18 years and older in identifying barriers that often result in relapse. The
implementation of MBI incorporates behavioral treatment focusing on individual responses to
high-risk situations along with skills training with cognitive interventions (Bowen et al., 2009).
Mindfulness behavioral treatment focuses on responses to high-risk situations, combining skillstraining with cognitive interventions (Bowen et al., 2014). The goal of MBI is decreasing the
risk and severity of relapse to substance use following treatment. Hence, predicting the
achievement of the project’s goal of reducing the rate of relapse related to SUD.
Short-term goal for the project was a 15% or more reduction in the risk of relapse in
patients who have participated in aftercare. The long-term goal is the achievement of a 25% or
more reduction in the risk of relapse and the incorporation of the MBRP intervention in the
policy and procedure for the rehabilitation facility with sustainability of this evidenced-based
project after 6 months.
A multidisciplinary team was formed to ensure a successful change project
implementation. The team consisted of the medical director, healthcare providers, mental health
therapist, the DNP student and office support staff. Each team member was made aware of their
roles and responsibilities and the project’s timeline and milestones. Expectations were clearly
communicated, and accountability established.
A timeline is important in implementing and achieving the goals of the project. The tasks,
assigned personnel, and allotted time frame are outlined in Appendix D. Reminding team
members of the project timeline was also essential to ensure achievement of assigned tasks. The
timeline began with preparing the project proposal and holding weekly meetings and/or
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conversations with the preceptor. Next, the DNP student secured an Evidence-Based Review
Council approval from the University of St. Augustine for Health Sciences (USAHS) and from
the facility. The next step included meeting with key stakeholders and training staff involved in
the implementation of the intervention. After the project implementation commenced, the data
collected was analyzed by the DNP student and a statistician. Finally, the results were
disseminated and presented.
Data Tool
The data collection included participants completing the Stimulant Relapse Risk Scale
(SRRS). SRRS is a scale designed to measure Relapse Risk among Substance Dependence. (See
Appendix F). SRRS is a 35 item self-report multidimensional instrument with a 5-point Likert
type rating scale with response options ranging from ‘strongly agree’ to ‘strongly disagree’. A
letter of approval was unnecessary to use this tool as the authors indicated free use of SRRS
without permission from the developer (Tokyo Metropolitan Institute of Medical Science) in
case of intended purpose for academic, clinical setting, and research. The only requirement was
citing the reference. (See Appendix G). The data were collected by the DNP student with PHI
being secured prior to collecting the data.
Reliability and Validity
Reliability and validity are fundamental features in the evaluation of data collection tool
for effectiveness. Inter-rater reliability is used to measure the data collected and help to
determine whether the data collection instrument is clear, relevant, reasonable and a valid
measuring tool.
The project manager has an important role in the success of any evidence-based project.
They must possess key leadership skills. These include: 1) organizing the project with specific
steps that provide structure and a framework that is easy to monitor and to change as needed; 2)
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engaging all members involved; 3) effectively managing the project in collaboration with others
at the microsystem level; 4) and controlling the project so that it is continually on time, on
budget, and within the scope of the requirements.
Evaluation Plan
The goal of this project was to reduce the risk of relapse in adults with a history of
substance use disorder. With rates of relapse following substance abuse treatment estimated over
60%, SUDs are often described as “chronic relapsing conditions” (Bowen et al., 2010). The
evaluation process is important in measuring success of the EBP and determining whether the
implementation of the intervention was effective. While statistical significance is important,
creating clinically significant results is also important for this EBP and the organization.
Monitoring and providing support to staff ensured that the independent variable of implementing
a mindfulness-based intervention directly caused the intended change of reducing the incidence
of relapse. The evaluation strategies used a pre and post questionnaire to measure the risk of
relapse for the participants of the study. This project demonstrated a decrease in the risk of
relapse for patients, which was achieved through the project interventions.
Data Source
The data source was an internally created tool documented on an Excel Spreadsheet. The
data's privacy and confidentiality were maintained by storing data in electronic files on a
password protected laptop. The laptop was stored in a locked desk drawer in a secured office. A
random identification number was assigned to each participant to de-identify data collected. No
PHI was included in the analytical dataset.
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Balancing Measures
Balancing Measures included the cost for consulting with a statistician to help interpret
the data, which cost $99. No additional cost was incurred because the staff were trained during
normal work hours and no additional supplies were needed or used.
Process Measures
The interventions were evaluated with process measures before and after implementation
to demonstrate fidelity to the new MBI. The intervention was measured for the percentage of
completion pre- and post-implementation .
Financial Measures
Financial measures evaluate costs associated with the project and overlaps with the
balancing measures. Again, the financial cost was minimum as staff was trained during normal
business hours and didn’t require any additional training outside of normal work hours.
Outcome Measures
The outcome measure was 15% or more reduction in the risk of relapse in patients who
have participated in the intervention. Therefore, this outcome measure was met.
Sustainability Measures
Sustaining measures were implemented to monitor the project over time. This data
allowed the organization’s leadership to continue to observe and monitor the project significance
and to ensure it aligns closely with the organization’s mission and values and there are resources
to promote sustainability.
Data Analysis
Data collection began after receiving approval from University of Saint Augustine’s
Evidence Practice Review Council (EPRC) and from the facility’s Executive Team. A data
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collection spreadsheet was developed by the DNP student and reviewed to ensure accuracy and
to ensure there was no duplication of data or missing data.
The participants for this study included adults 18 years and older with a history of
substance use disorder and were residents at a rehabilitation facility in April and May 2021.
Therefore, the first part of data collection addressed the demographic data that were collected to
describe the participants in the project. Data collected included age, gender, race, history of use
in years, number of days abstinent from substance use and outpatient or inpatient rehabilitation
treatment. Intellectus, a statistical software was used to analyses the data. Data obtained were
organized and presented utilizing frequency and percentage distribution figures. Summary
statistics were calculated for each interval and ratio variable. Frequencies and percentages were
calculated for each nominal variable. Frequencies and percentages are presented in Appendix H.
The second part of the data collection included the comparison between pre and post
intervention questionnaire. The outcome of the questionnaire is an important tool in monitoring
and providing support to the rehabilitation staff. The aim of the intervention was to improve
clinical significance of outcomes relevant to previous research. T-test was used to measure the
level of change from pre-intervention to post-intervention. The result of the two-tailed paired
sample t-test was significant based on an alpha value of 0.05, indicating the null hypothesis can
be rejected. This finding suggests the difference in the mean of relapse risk overall pre-test and
the mean of relapse risk overall post-test was significantly different from zero. Baseline
incidence rate for relapse was 2.85% and was reduced to 2.58% post intervention (Intellectus,
2021). The 0.27% reduction as significantly lower than the set goal of 15%. The results indicate
that the reduction in the risk of relapse in adult patients with a history of SUD post
implementation was not significantly significant. The results are presented in Appendix I.
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Impact
This project has addressed the practice problem by supporting the evidence that
mindfulness-based training can produce significant therapeutic effects on SUDs and prevent
relapse. Implementation of MBI positively impacted the level of awareness, both internally and
externally, of participants with a history of substance use and created an opportunity for them to
identify triggers versus instinctively using substances. Throughout the 8-week implementation
phase, the participants experienced a transformation that ultimately may reduce the risk of future
substance misuse.
The outcome from the implementation of Mindfulness Based Intervention was the
reduction in the incidence of relapse in adults with a history of substance abuse. Although the
reduction in the incidence of relapse was not statistically significant, the findings indicated a
clinically meaningful improvement on relapse outcomes post implementation.
The practice change encountered some challenges. Due to COVID 19, the rehabilitation
facility had to limit the number of residents which led to a smaller sample size. However, despite
the limited number of participants, the findings of the project still provided a reduction in
relapses, demonstrating an improvement post-implementation. Also, it is unknown whether MBI
is more efficacious as a stand-alone treatment or bridged with another treatment plan. Going
forward, this should be explored to see if MBI can provide the same results of reduction in
incidence of relapse or should it be used in conjunction with other treatment modalities for best
results and sustainability. Finally, it should be noted that pursuit of a healthy lifestyle is not
something that is finalized over the course of an 8-week intervention (Garland & Howard, 2015).
Hence, consideration should also be made with MBI and the need to be practiced postintervention in order to maintain therapeutic effects and achieve addiction recovery.
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Future Implications
The ongoing goal is sustainability and assisting the organization in standardizing an
effective and evidenced based treatment therapy. Suggestions for next step would include
incorporating the practice change as part of an individual’s treatment plan and providing longer
term follow up to assess the durability of observed treatment effects (Garland & Howard, 2015).
The implementation of this change project is aligned with the organization’s mission, vision, and
values. In order to ensure sustainability of the intervention, leadership must provide on-going
evaluations of its effectiveness. Thus, monitoring of the interventions and outcomes will
continue, and data will be reviewed by leadership on a bi-monthly basis.
Dissemination Plan
After the data collection and analysis, a PowerPoint presentation of the results and
evaluation of the project was presented to the project team. The Medical director, healthcare
providers, and mental health are the intended audience. For team members who could not attend
the meeting, an email was sent to summarize the findings. Peer reviews of the project results
was conducted prior to sharing the results. The peer reviews included constructive feedback from
the faculty advisor, preceptor, and writing center coach.
Regional and local organizations to which this could be presented would include other
substance abuse treatment centers within the state of Maryland. Nationally, there is an annual
NAADAC, the Association for Addiction Professionals, Conference. NAADAC represents the
professional interests of counselors, educators and other addiction-focused health care
professionals in the United States, Canada and abroad. Externally, The Journal of Addictions
Nursing (JAN), is the preferred journal for publication because it is a peer-reviewed quarterly
international journal publishing original articles on current research, issues, practices, and
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innovations as they relate to the field of addictions. A publication of the manuscript will be
submitted in full text to Scholarship and Open Access Repository (SOAR@USA) to fulfill the
DNP program requirements. The SOAR is an institutional repository for the university where
projects can be accessed and reviewed.
Conclusion
The paper aimed to evaluate the effect of mindfulness-based intervention (MBI)
implementation on relapse prevention in adults with a history of substance use disorder at a
rehabilitation facility after a two-month period. Research and evidence support the effectiveness
of healthcare professionals including therapist in implementing mindfulness-based intervention,
along with a multidisciplinary approach, audit, and feedback in reducing the incidence relapse.
A high staff compliance rate achieved on MBI will lead to a successful preventive measures
implementation and improve relapse rate in participants with a history of substance use disorder.
The outcome is aligned with the facility’s vision and mission of providing the highest quality of
care for patients and the community.
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Appendix A
PRISMA Flow Diagram

CINAHL
2012-2019
49 Citations

PubMed
2012-2019
136 Citations

Google Scholar
2012-2019
93 Citations

73 Non -Duplicated
Citations Screened

Inclusion/Exclusion
Criteria Applied

52 Articles Excluded
After Title/Abstract Screen

21 Articles Retrieved

Inclusion/Exclusion
Criteria Applied

11 Articles Included

11 Articles Excluded
After Title/Abstract Screen
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Evidence Table

Citation
Bowen, S., Witkiewitz, K.,
Clifasefi, S. L., Grow, J.,
Chawla, N., Hsu, S. H.,
Carroll, H. A., Harrop,
E., Collins, S. E.,
Lustyk, M. K., &
Larimer, M. E. (2014b).
Relative Efficacy of
Mindfulness-Based
Relapse Prevention,
Standard Relapse
Prevention, and
Treatment as Usual for
Substance Use
Disorders. JAMA
Psychiatry, 71(5), 547.
https://doi.org/10.1001/j
amapsychiatry.2013.454
6

Chiesa, A., & Serretti, A. (2013).
Are Mindfulness-Based
Interventions Effective
for Substance Use
Disorders? A Systematic
Review of the Evidence.
Substance Use &
Misuse, 49(5), 492–512.

Design Level/Quality
Grade
Level I; Quality Rating
A

Level III
Quality Rating B

Sample/Sample size
26 individuals who
successfully completed
initial treatment for
substance use disorders
at a private, nonprofit
treatment facility

24 studies retrieved from
four electronic databases
that supported MBIs

Intervention/Compari
son
To evaluate the longterm efficacy of MBRP
in reducing relapse
compared with RP and
treatment as usual
(TAU [12-step
programming and
psychoeducation])
during a 12-month
follow-up period.
Participants were
randomly assigned to 8
weekly group sessions
of Mindfulness Based
Relapse prevention,
Relapse prevention or
Treatment as usual after
successfully completing
initial treatment for
substance use disorders
12 months prior.

Theoretical
Foundation
None indicated

Outcome Definition

Reviewing current
evidence on the
therapeutic efficacy of
MBIs for substance use
and misuse. Focusing
on the usefulness of
MBIs for the reduction
of substance use and
misuse.

None Indicated

Measuring the
difference between
MBIs and active or
inactive comparators
on measures of
objective and
subjective substance
use or misuse
reduction.

Primary outcome is a
decrease in relapse to
drug use and heavy
alcohol and
frequency of
substance use in 90
days.

Usefulness Results/Key
Findings
At the 12-month follow-up,
MBRP participants reported
significantly fewer days of
substance use compared with
RP and TAU.

MBIs can reduce
consumption of several
substances and can improve
several psychological
outcomes associated with
drug consumption.
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Davis, J. P., Berry, D., Dumas, T.
M., Ritter, E., Smith, D.
C., Menard, C., &
Roberts, B. W. (2018).
Substance use outcomes
for mindfulness-based
relapse prevention are
partially mediated by
reductions in stress:
Results from a
randomized trial.
Journal of Substance
Abuse Treatment, 91,
37–48.
https://doi.org/10.1016/j.
jsat.2018.05.002
Dingle, T., & Bowen, S. (2021).
Evaluating substance use
treatment efficacy for
younger and older
adults. Addictive
Behaviors, 112, 106618.
https://doi.org/10.1016/j.
addbeh.2020.106618

Grant, S., Colaiaco, B., Motala,
A., Shanman, R., Booth,
M., Sorbero, M., &
Hempel, S. (2017).
Mindfulness-based
Relapse Prevention for
Substance Use
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Level I
Quality Rating B

79 adults over the age of
18 years from a
residential substance use
treatment center.

To examine the effect
of the experimental
condition (treatment as
usual + MBRP)
compared to a control
condition (treatment-asusual plus additional
12-step meetings
(TAU)) on perceived
stress, craving and
substance use.

None indicated

The number of
participants who
self-reported
measures of stress,
craving, and
substance use.

Substance use increased
relatively rapidly,
immediately following
treatment discharge for
individuals assigned to TAU
with sustained low
endorsement of substance use
over the 6-month follow-up
period for those assigned to
MBRP.

Level I
Quality Rating A

221 in a communitybased SUD aftercare;
107 adults under 40;
adults over 40= 140

To examine the
differential efficacy of
aftercare substance use
treatments for younger
versus older adults

None Indicated

Older participants in MBRP
had significantly higher
abstinence rates compared
with those in TAU. Further,
the older individuals in
MBRP had a significantly
lower percent of days on
which they used compared
with those in TAU and RP

Level 1
Quality Rating A/B

9 randomized controlled
trials comprising 901
adult participants who
were 18 years of age or
older.

Comparing previous
RCTs and evaluating
the effects and safety of
MBRP for adults with
SUDs.

None indicated

Prevalence- rates of
abstinence and
percent use days at
1-year follow-up,
compared between
standard cognitive
behavioral relapse
prevention (RP),
Mindfulness-Based
Relapse Prevention
(MBRP), and 12step-based treatment
as usual (TAU).
To provide
comprehensive
estimates of the
effects of MBRP on
specific patientimportant clinical
outcomes to

No statistically significant
differences between MBRP
and comparators on relapse
when comparing all 9 RCT’s.
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Disorders. Journal of
Addiction Medicine,
11(5), 386–396.
https://doi.org/10.1097/a
dm.0000000000000338

subsequently inform
guidelines about
whether to
recommend its use in
everyday practice.

Grow, J. C., Collins, S. E.,
Harrop, E. N., & Marlatt,
G. A. (2015). Enactment
of home practice
following mindfulnessbased relapse prevention
and its association with
substance-use outcomes.
Addictive Behaviors, 40,
16–20.
https://doi.org/10.1016/j.
addbeh.2014.07.030

Level I
Quality Rating B

168 adults with
substance use disorder
who were recruited from
a community treatment
agency

Examining the
relationships between
treatment enactment
(i.e., home mindfulness
practice) and alcohol
and other drug (AOD)
use and craving in the
context of a larger study
of mindfulness-based
relapse prevention
(MBRP).

None Indicated

Kargin, M., & Hicdurmaz, D.
(2020). Psychoeducation
Program for Substance
Use Disorder: Effect on
Relapse Rate, Social
Functioning, Perceived
Wellness, and Coping.
Journal of Psychosocial
Nursing and Mental
Health Services, 58(8),
39–47.
https://doi.org/10.3928/0
2793695-20200624-03

Level 2
Quality Rating A/B

The study sample
comprised 92 individuals
(n = 46 intervention
group, n = 46 control
group) who received
SUD treatment

To assess the effect of a
psychoeducation
program on relapse rate,
social functioning,
perceived wellness, and
ways of coping in
individuals with
substance use disorder
(SUD) who have
received treatment and
are in recovery.

None Indicated

The number of
participants who
increased the amount
of time spent in
home mindfulness
practice over the
course of the study.
AOD use, craving,
and home
mindfulness practice
were assessed at
baseline, posttreatment, 2-month
and 4-month followup time points.
To determine the
effects of a relapse
prevention
psychoeducation
program such as
Mindfulness Based
Relapse Prevention,
on relapse rate,
social functioning,
perceived wellness,
and ways of coping
in individuals with
SUD.

MBRP participants
significantly increased the
amount of time spent in
home mindfulness practice
over the course of the study.
Further, greater time spent in
home practice was associated
with less AOD use and
craving at the 2- and 4-month
follow-ups

Relapse prevention
psychoeducation program led
to positive changes in relapse
rate, social functioning,
perceived wellness, and
stress in individuals with
SUD
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Korecki, J. R., Schwebel, F. J.,
Votaw, V. R., &
Witkiewitz, K. (2020b).
Mindfulness-based
programs for substance
use disorders: a
systematic review of
manualized treatments.
Substance Abuse
Treatment, Prevention,
and Policy, 15(1), 51.
https://doi.org/10.1186/s
13011-020-00293-3

Level 1
Quality Rating B

30 studies
collaboratively from
PubMed, Psych INFO,
and Web of Science
databases from January
2016 to April 2020.

Comparing studies that
examined the effects of
MBI and employed a
RCT design with
repeated measures, that
enrolled participants
seeking treatment for
substance use disorder

None Indicated

To determine
whether MBIs
appear to be as
effective at reducing
the frequency and
quantity of alcohol
and drug use and
other substance
related problems,
therefore increasing
the rate of
abstinence.

MBIs is an effective tool for
the treatment of substance
use disorders, craving for
substance use, and at
increasing the rate of
abstinence.

Li, W., Howard, M. O., Garland,
E. L., McGovern, P., &
Lazar, M. (2017).
Mindfulness treatment
for substance misuse: A
systematic review and
meta-analysis. Journal of
Substance Abuse
Treatment, 75, 62–96.
https://doi.org/10.1016/j.
jsat.2017.01.008

Level 1
Quality Rating B

42 pertinent studies from
PubMed, PsycInfo, and
Web of Science

Mindfulness treatment
for substance misuse is
a promising
intervention for
substance misuse and in
reducing the frequency
and severity of
substance misuse,
intensity of craving for
psychoactive
substances, and severity
of stress.

None Indicated

Decreases in
substance misuserelated behaviors and
problems, including
severity of substance
misuse, craving for
substances, and
substance use-related
problems at
posttreatment and
follow-up
assessments.

Mindfulness treatment was
superior to control conditions
(e.g., TAU, relapse
prevention treatment, CBT,
and active support group) in
reducing the frequency and
amount of alcohol and drug
use, number of alcohol and
drug related problems, and
level of craving for substance
use, and in increasing
abstinence rates

Witkiewitz, K., Bowen, S.,
Douglas, H., & Hsu, S.
H. (2013b).
Mindfulness-based
relapse prevention for
substance craving.
Addictive Behaviors,
38(2), 1563–1571.

Level 1
Quality Rating B

168 clients from a
private, non-profit
treatment agency

Examining MBRP as an
aftercare treatment for
SUD and evaluating
potential mechanisms
by which MBRP might
be associated with
lower levels of craving
(urge or desire to use
substances).

None indicated

Significant lower
levels of craving
following MBRP
treatment. Craving
scores calculated
using a possible
range of 0 to 6 with
0= no cravings and

Participating in MBRP was
associated with significant
reductions in self-reported
craving during and following
treatment
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6= constant thoughts
of craving.
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Appendix C
SWOT Analysis
Strength
•

Weakness

Relapse rate data that supports the

•

Public awareness of the services

need for the project, multidisciplinary

•

Lack of participation among

team with open to feedback from

participants

stakeholders
•

Highly experienced clinical team
Opportunities

•

•

Threat

Interest in providing support to

•

Time constraints

participants at risk for relapse

•

Occurring pandemic

Networking with community

•

Failure to document correctly

stakeholders

•

Lack of motivation to complete the
questionnaire.
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Appendix D
Project Timeline
Task

Time Frame

Who is Responsible?

1. Prepare Project
proposal
2. IRB approval from the
University and Facility
3. Meet with key
stakeholders

9/10/2020-12/15/2020

DNP Student

1/15/2021-2/14/2021

DNP Student

4. Educate/train staff
5. Start Intervention
(MBRP)
6. Data Analysis
7. Dissemination of
Results

2/20/2021-3/5/2021
3/15/2021-5/15/2021

2/15/2021

6/1/2021-6/15/2021
7/1/2021-7/23/2021

DNP Student, Medical
Director, Healthcare
Professionals and Therapist
DNP Student and Therapist
DNP Student and Healthcare
Professionals/Therapist
DNP student and Statistician
DNP student
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Appendix E: Budget
Expenses

Revenue

Direct:

Billing

$0

Supplies

$0

Grants

$0

Staff Training

$0

Institutional Budget

$0

Support
Services

$99

(Statistician)
Indirect:
Overhead

$0

Total Expense

$99
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Appendix H
Frequency Table for Nominal Variables
Variable
n
Gender
M
5
F
7
Missing
0
Race
AA
9
Caucasian
2
Other
1
Missing
0
treatment_program_type
I
8
O
4
Missing
0
Note. Due to rounding errors, percentages may not equal 100%.

size.

%
41.67
58.33
0.00
75.00
16.67
8.33
0.00
66.67
33.33
0.00

Summary Statistics Table for Interval and Ratio Variables
Variable
M
SD
n
Min
Age
35.83
9.81
12
21.00
Hx_of_use_in_yrs
15.58
11.24
12
2.00
X_days_of_abstinence
63.42
18.59
12
33.00
Note. '-' indicates the statistic is undefined due to constant data or an insufficient sample

Max
54.00
36.00
89.00
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Two-Tailed Paired Samples t-Test for the Difference Between RelapseRisk_Overall_Pretest and RelapseRisk_Overall_Post
RelapseRisk_Overall_Pretest
RelapseRisk_Overall_Post
M
SD
M
SD
t
p
d
2.85
0.19
2.58
0.14
6.27
< .001
1.81
Note. N = 12. Degrees of Freedom for the t-statistic = 11. d represents Cohen's d.
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